Moberg Pharma reports 2025 annual results, maintains strong cash position

The company reported net revenue of SEK 13.5 million for the full year 2025

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility

ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi

Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region

Botanic Healthcare appoints Kamalakar V. Arcot as Group CEO

Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce

New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education

Microbot Medical begins full US market release of LIBERTY endovascular robotic system

Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district